Genetic Technologies Ltd

Founded in 1989, Genetic Technologies Limited is an established Australian-based molecular diagnostics company specialising in women’s health. The Company offers predictive testing and assessment tools to help physicians proactively manage women’s health. The Company’s lead product,BREVAGenplus®, is a clinically validated risk assessment test for non-hereditary breast cancer and is first in its class.The Company markets BREVAGenplusto healthcare professionals in comprehensive breast health care and imaging centres, as well as to obstetricians/gynaecologists (OBGYNs) and breast cancer risk assessment specialists (such as breast surgeons).

Bank Name Genetic Technologies Ltd
Stock Exchange NASDAQ
Symbol GENE
Sector Healthcare
Industry Biotechnology: Biological Products
Country United States
World Region America
Chairman Dr. Paul Alexander Kasian Ph.D.
CEO Dr. Paul Alexander Kasian Ph.D.
Registered Year 1989